BACE/APPV717F Double-Transgenic Mice Develop Cerebral Amyloidosis and Inflammation
Authors:
- Laurence OzmenLOLaurence Ozmen
- Marie WoolleyMWMarie Woolley
- Anita AlbientzAAAnita Albientz
- Marie- ThereseMTMarie- Therese
- Peter NelboeckPNPeter Nelboeck
- Pari MalherbePMPari Malherbe
- Christian CzechCCChristian Czech
- Fiona Grüninger-LeitchFGFiona Grüninger-Leitch
- Manfred BrockhausMBManfred Brockhaus
- Theresa BallardTBTheresa Ballard
- Helmut JacobsenHJHelmut Jacobsen
- 1 January 2005
- journal article
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 2 (6) , 284-298
Abstract
Most of the transgenic mice generated to model Alzheimer’s disease express human amyloid precursor protein (APP) mutants alone or in conjunction with presenilin mutants. We have generated a mouse model by overexpressing human BACE and human APP with the V717F mutation. The combination of a mutation at the γ-secretase cleavage site of APP and of increased β-secretase activity should favour the production of amyloid peptides. We analysed double BACE/APPIn and single APPIn transgenic mice at 16–18 months for amyloid load, brain histopathology and behavioural deficits. We show that overexpression of BACE induces an increase in APP CTFβ and total brain Aβ peptides. Brain histopathology shows clearly enhanced amyloid deposits in the cortex, hippocampus and in brain vasculature when compared to single APPIn transgenic mice. Amyloid deposits are mostly diffuse and predominantly composed of Aβ42. A strong inflammatory reaction is evidenced by the presence of microglial cells around the most mature amyloid deposits and astrocytosis over the entire cerebral cortex. At the same age, the APPIn single-transgenic mice show only very limited pathology. When assessed for their cognitive performance at 12 months, BACE/APPIn mice show impaired spatial acquisition in the Morris water maze test. However, these deficits are not greater than those observed in the APPIn single-transgenic animals.Keywords
This publication has 53 references indexed in Scilit:
- Altered Amyloid-β Metabolism and Deposition in Genomic-based β-Secretase Transgenic MiceJournal of Biological Chemistry, 2004
- Dimeric Amyloid β Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2004
- Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathologyJournal of Neural Transmission, 2004
- The Human Amyloid-β Precursor Protein770 Mutation V717F Generates Peptides Longer Than Amyloid-β-(40-42) and Flocculent Amyloid AggregatesJournal of Biological Chemistry, 2004
- Genetic background regulates -amyloid precursor protein processing and -amyloid deposition in the mouseHuman Molecular Genetics, 2003
- A vector for expressing foreign genes in the brains and hearts of transgenic miceGenetic Analysis: Biomolecular Engineering, 1996
- Lack of β-Amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutationsNeurobiology of Aging, 1996
- A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's DiseaseScience, 1991
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984